Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Mark Schlegel, PhD Senior Scientist, RNAi Discovery at Alnylam Pharmaceuticals


Mark joined Alnylam Pharmaceuticals in 2014 where he is currently a Senior Scientist in the RNAi Discovery group. At Alnylam, Mark oversees high throughput synthesis operations in support of siRNA lead finding and platform development efforts. Prior to joining Alnylam, Mark held the position of Head of Automation at GlycoUniverse GmbH & CO KGaA. Mark received his undergraduate degree in chemistry from Moravian College, a PhD in Chemical Biology from the University of Pennsylvania, and was a postdoctoral fellow at the Max Planck Institute of Colloids and Interfaces.

Agenda Sessions